Abstract:Objective:To explore the improvement of bone mineral density by deferoxamine (DFO) effects on blood vessels in bone.Methods:Thirty C57BL/6J wild-type mice were used for this experiment (Model Animal Research Center of Nanjing University). Eight-week-old female mice were randomly divided into three groups including a sham operation (Sham), bilateral ovariectomy (OVX) and intraperitoneal injection DFO (OVX+ DFO). There are ten mice in every group. In the sham group, the ovaries were only exposed but left intact. The bilateral ovaries were exposed and complete excision in the OVX group. In the OVX+ DFO group, the mice were treated with DFO intervention four weeks by intraperitoneal injection every other day. In the other two groups, the mice were administrated with normal saline equivalent. After 4 weeks, these mice were killed for experiment and the femurs were collected for Micro-CT scanning in order to observe the changes of bone mineral density (BMD) and trabecular indexes, including bone volume fraction (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp) and connectivity density (Conn. Dn). The fresh tibia of each mouse was fixed, decalcified, dehydrated and embedded for immunostaining in order to observe the type H vessels in the metaphysis of the bone. All experimental data were collected for statistical analysis by single factor Analysis of Variance (ANOVA).Results:Mouse femora from three groups were dissected at 4-week time points, and the attached soft tissue was completely removed for Micro-CT scanning. The value of BMD is (0.18±0.01) g/cm 3 in Sham group, (0.12±0.00) g/cm 3 in OVX group and (0.16±0.01) g/cm 3 in OVX+ DFO, which indicated the BMD in OVX + DFO group significantly improved by comparing with OVX group. The results showed significant difference among the groups ( F=20.790, P<0.01). The microarchitecture in trabecular bone had changed. The value of BV/TV is (11.47±0.79)% in OVX group, (26.05±2.05)% in Sham group and (18.44±3.26)% in OVX+ DFO group, which indicated the BV/TV in OVX significantly decreased and some improvement in DFO interventions. The results showed significant difference among the groups ( F=31.000, P<0.01). The number of Tb.N is (1.63±0.15)/mm in OVX group, (2.81±0.13)/mm in Sham group, and (2.36±0.43)/mm in OVX+ DFO group, which indicated the Tb.N in OVX+ DFO group increased. The results showed significant difference among the groups ( F=14.290, P<0.01). The value of Tb.Th in OVX group is (0.05±0.01) mm, (0.07±0.00) mm in Sham group and (0.06±0.00) mm in OVX+ DFO group, which indicated the Tb.Th in OVX+ DFO group significantly thickened. The results showed significant difference among the groups ( F=20.060, P<0.01). Tb.Sp in OVX group is (0.29±0.03) mm, (0.19±0.01) mm in Sham group and (0.24±0.04) mm in OVX+ DFO group, which indicated the Tb.Sp in OVX significantly increased and partially improved via DFO interventions. The results showed significant difference among the groups ( F=9.450, P<0.05). Conn. Dn in Sham group is (202.67±37.75)/mm 3, (97.85±8.62)/mm 3 in OVX group and (115.79±15.90)/mm 3 in OVX+ DFO group. The results showed significant difference between the groups ( F=16.140, P<0.01). The tibialspecimes were collected for immunostaining in order to observe the changes of type H vessel in the metathysis of the bone among the three groups. The area of type H vessels in bone was calculated. The percentage of HV/TV in Sham group was (26.28±1.23)%, (8.72±0.85)% in OVX group and (17.25±2.14)% in OVX+ DFO group. Dramatically increased type H vessels in the metaphysis of OVX+ DFO group were observed compared with that of OVX group. The results showed significant difference among the groups ( F=160.000, P<0.01). Conclusion:The ovariectomized mice model study, type H vessels in bone involved the occurrence of osteoporosis. DFO maybe improve the bone mineral density by enhancing the type H vessels formation.

Experimental Study on the Prevention of Bone Loss by Deferoxamine in Type 1 Diabetic Mice with Osteoporosis

Prevention of Bone Loss in Type I Diabetic Osteoporosis Mice by Hypoxia Mimicking Agent Deferoxamine

Experimental research of deferoxamineon the improvement of bone mineral density via enhancing angiogenesis in bone

Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice.

The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions

Osteoking prevents bone loss and enhances osteoblastic bone formation by modulating the AGEs/IGF-1/β-catenin/OPG pathway in type 2 diabetic db/db mice

Ziyin Bushen Fang improves Diabetic Osteoporosis by Inhibiting Autophagy and Oxidative Stress In vitro and In vivo

Effect of deferoxamine on the bone-related gene expression in human osteoblasts in vitro

Effects of Low-Intensity Pulsed Electromagnetic Fields on Bone Microarchitecture, Mechanical Strength and Bone Turnover in Type 2 Diabetic Db/db Mice

Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP-1 in type I diabetic mice

The Protective Effects of Silibinin in the Treatment of Streptozotocin-Induced Diabetic Osteoporosis in Rats

SF-deferoxamine, a Bone-Seeking Angiogenic Drug, Prevents Bone Loss in Estrogen-Deficient Mice

Effect of deferoxamine administration on the treatment of iron accumulation-induced osteopenia in male mice

Traditional Chinese Medicine Bushen-Jianpi-Huoxue Decoction Prevents Diabetic Osteoporosis in Rats Via Wnt and Nuclear Factor-Kappa B Signaling Pathways.

Analysis of bone metabolic alterations linked with osteoporosis progression in type 2 diabetic db/db mice

Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice

Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice Through Enhanced Angiogenesis and Osteogenesis

Effects of Different Exercises on cAMP/CREB/ATF4 Pathway and Bone Formation in Bone of T2DM Mice

Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis Via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats

Fenofibrate Decreases the Bone Quality by Down Regulating Runx2 in High-Fat-diet Induced Type 2 Diabetes Mellitus Mouse Model

Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice